<img alt="" height="1" width="1" />
Rivaroxaban Wins FDA Approval for DVT Prevention
MedPage Today
WASHINGTON -- The FDA has approved rivaroxaban (Xarelto), an oral, once-daily, factor Xa inhibitor for prevention of deep vein thrombosis in patients undergoing knee or hip replacement surgery, ...
J&J-Bayer Win US Approval in Surgery for Much-Anticipated Blood ThinnerBloomberg
FDA approves new anticlot drug from J&J and bayerMarketWatch
FDA Approves XARELTO® (rivaroxaban tablets) to Help Prevent Deep Vein ...PR Newswire (press release)
Newsday (subscription) -Virtual Press Office (press release)
all 149 news articles &raquo;